BACKGROUND: This systematic literature review of the epidemiology of Guillain-Barré syndrome (GBS) identifies trends in incidence rates by age, study method and cause of disease. It is important to have a reliable estimate of incidence to determine and investigate any changes: no previous systematic reviews of GBS have been found. METHODS: After critical assessment of the reliability of the reported data, incidence rates were extracted from all relevant papers published between 1980 and 2008, identified through searches of Medline, Embase and Science Direct. RESULTS: Sixty-three papers were included in this review; these studies were prospective, retrospective reviews of medical records or retrospective database studies. Ten studies reported on the incidence in children (0-15 years old), and found the annual incidence to be between 0.34 and 1.34/100,000. Most studies investigated populations in Europe and North America and reported similar annual incidence rates, i.e. between 0.84 and 1.91/100,000. A decrease in incidence over the time between the 1980s and 1990s was found. Up to 70% of cases of GBS were caused by antecedent infections. CONCLUSIONS: Our best estimate of the overall incidence of GBS was between 1.1/100,000/year and 1.8/100,000/year. The incidence of GBS increased with age after 50 years from 1.7/100,000/year to 3.3/100,000/year. 2008 S. Karger AG, Basel.
BACKGROUND: This systematic literature review of the epidemiology of Guillain-Barré syndrome (GBS) identifies trends in incidence rates by age, study method and cause of disease. It is important to have a reliable estimate of incidence to determine and investigate any changes: no previous systematic reviews of GBS have been found. METHODS: After critical assessment of the reliability of the reported data, incidence rates were extracted from all relevant papers published between 1980 and 2008, identified through searches of Medline, Embase and Science Direct. RESULTS: Sixty-three papers were included in this review; these studies were prospective, retrospective reviews of medical records or retrospective database studies. Ten studies reported on the incidence in children (0-15 years old), and found the annual incidence to be between 0.34 and 1.34/100,000. Most studies investigated populations in Europe and North America and reported similar annual incidence rates, i.e. between 0.84 and 1.91/100,000. A decrease in incidence over the time between the 1980s and 1990s was found. Up to 70% of cases of GBS were caused by antecedent infections. CONCLUSIONS: Our best estimate of the overall incidence of GBS was between 1.1/100,000/year and 1.8/100,000/year. The incidence of GBS increased with age after 50 years from 1.7/100,000/year to 3.3/100,000/year. 2008 S. Karger AG, Basel.
Authors: Cintya O Souza; Marcelo A C S Vieira; Francisca M A Batista; Kelsen D Eulálio; Jéssica M M Neves; Laís C Sá; Leni C R Monteiro; Walfrido S Almeida-Neto; Raimunda S S Azevedo; Dorcas L Costa; Ana C R Cruz Journal: Am J Trop Med Hyg Date: 2018-01-04 Impact factor: 2.345
Authors: Farrah J Mateen; David R Cornblath; Hamid Jafari; Russell T Shinohara; Devendra Khandit; Bina Ahuja; Sunil Bahl; Roland W Sutter Journal: Vaccine Date: 2011-10-11 Impact factor: 3.641
Authors: Chelsea G Major; Emilio Dirlikov; Nicole A Medina; Roberta Lugo-Robles; Desiree Matos; Jorge Muñoz-Jordán; Candimar Colón-Sánchez; Myriam García-Negrón; Marangely Olivero-Segarra; Graciela Malavé-González; Dana L Thomas; Carlos A Luciano; Stephen H Waterman; James Sejvar; Tyler M Sharp; Brenda Rivera-García Journal: P R Health Sci J Date: 2018-12 Impact factor: 0.705
Authors: Emilio Dirlikov; Chelsea G Major; Nicole A Medina; Roberta Lugo-Robles; Desiree Matos; Jorge L Muñoz-Jordan; Candimar Colon-Sanchez; Myriam Garcia; Marangely Olivero-Segarra; Graciela Malave; Gloria M Rodríguez-Vega; Dana L Thomas; Stephen H Waterman; James J Sejvar; Carlos A Luciano; Tyler M Sharp; Brenda Rivera-García Journal: JAMA Neurol Date: 2018-09-01 Impact factor: 18.302